- Advertising
- Asia
- Bangladesh
- Biological Inventions
- BRAND VALUATION
- China
- Comparative Advertisement
- Copyright
- Copyright Infringement
- Copyright Litigation
- Counterfeiting
- Covid
- Data Protection
- Design
- Digital Marketing Rights
- DRM
- Electronics
- Geographical Indication
- India
- Indian Patents Act
- Indonesia
- Intellectual Property
- Interim Injunction
- IP Commercialization
- IP Licensing
- IP Litigation
- IP Practice in India
- IPAB
- IPAB Decisions
- Japan
- Legal Issues
- Licensing
- Malaysia
- Myanmar
- NCLT
- NEPAL
- Net Neutrality
- News & Updates
- Office
- Patent Commercialisation
- Patent Cooperation Treaty
- patent infringement
- Patent Licensing
- Patent Litigation
- Patent Opposition
- Patent Prosecution
- Patent Rule Amendment
- Patent Term Extension
- Patents
- pharma
- Philippines
- Punitive Damages
- Section 3(D)
- section 64
- Singapore
- South-east Asia
- Technology
- Technology Transfer
- Thailand
- Trademark
- Trademark Litigation
- UAE
- Uncategorized
- USPTO
- Vietnam
- WIPO
Suggested Reform In Patent Law : Revolutionary Or Problematic ?
“Recently the Economic Advisory council to PM said in a presentation to the stakeholder ministries like NITI Aayog and Department of Promotion of Industry and Internal Trade (DPIIT) for a slight change in the Indian patent working by suggesting recruitment of more patent officers and by fixing six months as the time period so the … Continue reading Suggested Reform In Patent Law : Revolutionary Or Problematic ?
Read more »Sofosbuvir: The Next Pre-Grant Opposition Target by I-MAK
After anti-influenza drug Tamiflu (Oseltamivir Phosphate) and antiretroviral drug Viread, Gilead Sciences is again back in news, this time with its hepatitis C (HCV) drug Sofosbuvir. Like Tamiflu and Viread’s pre-grant opposition, Sofosbuvir patent application is also facing pre-grant opposition. Non-profit group I-MAK (Initiative for medicines access and knowledge) has filed a pre-grant opposition against … Continue reading Sofosbuvir: The Next Pre-Grant Opposition Target by I-MAK
Read more »Draft Patents (Amendment) Rules 2013
Indian Patent Office (IPO) has recently published Draft Patents (Amendment) Rules 2013 and has invited comments (objections or suggestions) from the public within 45 days from the publication of the notification (12th June 2013). The main changes proposed are the following: 1. There is a 100% hike in official fees for almost all the proceedings … Continue reading Draft Patents (Amendment) Rules 2013
Read more »